Should I Buy BXP? BXP 2026 Analysis

Should You Buy BXP Inc (BXP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Sell

Latest Price

64.720

1 Day change

2.45%

52 Week Range

79.330

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient buyer: price trend is still bearish and momentum is deteriorating.
Downside risk remains elevated near key support (~62.91); a clean break could invite a quick move toward ~61.71.
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.
Options flow is mixed (bullish longer-term positioning, but bearish/defensive near-term volume), aligning with “uncertain/fragile” sentiment rather than a clean dip-buy.

Technical Analysis

Trend: Bearish structure with SMA_200 > SMA_20 > SMA_5, indicating persistent downtrend across timeframes.
Momentum: MACD histogram -0.197 and negatively expanding → selling pressure is increasing, not stabilizing yet.
RSI: RSI(6) ~24.7 (very weak/oversold reading) can spark short bounces, but oversold alone is not a durable buy signal while MACD worsens.
Levels: Pivot 64.857 is the near-term “line in the sand” for any bullish reversal attempt.
- Support: S1 62.911, then S2 61.708.
- Resistance: R1 66.803, R2 68.006.
Pattern-based odds provided: expected drift -1.39% (1 week) and -2.6% (1 month) → near-term bias remains downward.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Positioning vs flow: OI put-call 0.71 suggests more call open interest (mildly bullish positioning), but volume put-call 1.42 signals bearish/hedging demand in today’s activity.
Activity spike: Today’s option volume vs 30-day avg = 15.71x → elevated attention/event-driven trading.
Volatility: 30D IV 31.49 vs HV 26.34 (IV > realized) and IV percentile 65.6 → options are relatively expensive; market is pricing uncertainty.
Net read: sentiment is cautious-to-bearish near-term, not a strong “risk-on” signal for buying stock immediately.

Technical Summary

Sell

Buy

Positive Catalysts

- Outlook: 2026 FFO guide $6.88–$7.04 and expected occupancy improvement 86.7% → 89% (fundamental stabilization narrative).

Neutral/Negative Catalysts

- Earnings quality headline: Q4 FFO missed guidance (higher G&A cited), which can pressure near-term confidence.
- Price action/technicals: downtrend intact (bearish MAs + worsening MACD) → rallies may be sold until trend reverses.
- Options tape: near-term put-heavy volume implies hedging/negative sentiment into the next window.
- Office sector overhang: multiple analysts keep Neutral/Hold framing due to persistent office REIT challenges.
- Influential/insider/political activity: No recent congress trading data available; insiders/hedge funds flagged as Neutral, providing no supportive “smart money” tailwind.

Financial Performance

Latest quarter: 2025/Q4.
Revenue: $873.1M (+2.22% YoY) → modest top-line growth.
Profitability: Net income $248.5M (-208.58% YoY) and EPS $1.56 (-207.59% YoY) → sharp decline (suggests significant non-operational/one-time impacts or pressure versus prior year comps).
Margin: Gross margin 33.03% (down ~2.97% YoY) → mild compression.
Net read: fundamentals show improving activity (leasing/occupancy guidance) but reported earnings volatility is a headwind for near-term multiple expansion.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: more price-target trims than raises after Q4/sector model updates (Citi, Truist, Evercore, UBS, Cantor, Barclays, Mizuho mostly lowered targets).
Bull case on the Street: selective optimism (e.g., BofA Buy, PT $84) focused on execution toward 2026 goals, leasing/transactions momentum.
Base/bear case on the Street: many Neutral/Hold stances (Citi/UBS/Truist/Deutsche/Evercore) reflecting ongoing office sector challenges and softer near-term earnings optics.
Overall: Wall Street view is mixed-to-cautious, supportive of long-term stabilization but not unanimously bullish at current timing.

19 Analyst Rating

Wall Street analysts forecast BXP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BXP is 77.68 USD with a low forecast of 65 USD and a high forecast of 90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

10 Buy

9 Hold

0 Sell

Moderate Buy

Current: 63.170

Low

Averages

77.68

High

Current: 63.170

Low

Averages

77.68

High

Goldman Sachs

Neutral

downgrade

$75 -> $72

AI Analysis

2026-02-04

New

Reason

Goldman Sachs

Price Target

$75 -> $72

AI Analysis

2026-02-04

New

downgrade

Neutral

Reason

Goldman Sachs lowered the firm's price target on BXP to $72 from $75 and keeps a Neutral rating on the shares. The firm is updating its model after the company's Q4 results, while noting that the REIT is making progress on dispositions, also rolling its AFFO estimates forward a quarter, the analyst tells investors in a research note.

Citi

Neutral

downgrade

$70 -> $68

2026-02-03

New

Reason

Citi

Price Target

$70 -> $68

2026-02-03

New

downgrade

Neutral

Reason

Citi lowered the firm's price target on BXP to $68 from $70 and keeps a Neutral rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BXP

Unlock Now

BXP Should I Buy

BXP Should I Buy

Should You Buy BXP Inc (BXP) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch